Article Per Year (5 Year)
p-Index From 2019 - 2024
0.444
P-Index
This Author published in this journals
All Journal Medula
Alfina Indah Nabila
Lampung University
Education Medicine & Pharmacology Neuroscience Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Thr Usage Comparison of Chloramphenicol and Levofloxacin as Therapy for Bacterial Conjunctivitis Alfina Indah Nabila; yusran; rasmi zakiah oktarlina
Medula Vol 11 No 4 (2021): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v11i4.305

Abstract

Conjunctivitis is one of the most common eye diseases. Bacterial conjunctivitis ranks second after viral conjunctivitis as the most common cause of infectious conjunctivitis. Bacterial conjunctivitis can affect anyone of all ages, both men and women. One of the non-gonococcal bacteria that often causes eye infections is Staphylococcus aureus. Staphylococcus aureus generally affects adults more often than children Although rarely causes severe complaints, bacterial conjunctivitis can interfere with daily activities such as work or school. Bacterial conjunctivitis usually resolves on its own within 7 days but may continue for up to 2 weeks. Prescribing antibiotics in bacterial conjunctivitis can reduce complaints in patients and can also speed up healing. Selection of the right antibiotic is very important in order to obtain the desired treatment results. Chloramphenicol and levofloxacin are antibiotics with a broad spectrum that can be an option for the treatment of bacterial conjunctivitis caused by Staphylococcus aureus bacteria.
Potensi Astragalus Sebagai Terapi Adjuvan Pada Pasien Glomerulonefritis Alfina Indah Nabila; Nabila Rayhan Yasmin; Rani Himayani; Ramadhan Triyandi
Medula Vol 13 No 5 (2023): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v13i5.783

Abstract

Glomerulonephritis is a medical term used to describe a condition that involves some kidney damages. Glomerulonephritis is an abnormality of the kidney that may lead to end-stage renal disease (ESRD). The current glomerulonephritis therapy is considered not fully effective due to the possibility of additional morbidity and complications that may occur. The use of Astragalus as adjuvant therapy can inhibit the progression of glomerulonephritis. The journals, that was reviewed, obtained from the Google Scholar, Sciencedirect, PubMed, and Springer with a publication year range of 2009-2023. The journals were selected to obtain valid and reliable journals, then do a literature review and article writing. Astragalus membranaceus has a bioactive content that can act as an immunomodulator, antiinflamation, and renoprotector. Astragalus is able to improve kidney function through IL-6 secretion and improve kidney interstitial fibrosis. Administration of Astragalus in combination with conventional therapy can reduce serum creatinine and proteinuria. Astragalus has potential as adjuvant therapy in glomerulonephritis patients.
Co-Authors Nabila Rayhan Yasmin Ramadhan Triyandi Rani Himayani Rasmi Zakiah Oktarlina yusran